Skip to Content

Ocrevus Prices, Coupons and Patient Assistance Programs

Ocrevus (ocrelizumab) is a member of the CD20 monoclonal antibodies drug class and is commonly used for Multiple Sclerosis.

Ocrevus Prices

This Ocrevus price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Ocrevus intravenous solution (300 mg/10 mL) is around $16,974 for a supply of 10 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Intravenous Solution

300 mg/10 mL Ocrevus intravenous solution
from $16,973.56 for 10 milliliters
Quantity Per unit Price
10 milliliters $1,697.36 $16,973.56

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

Print Now

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 63,000 pharmacies nationwide.


Ocrevus Coupons and Rebates

Ocrevus offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Ocrevus Co-Pay Program: Eligible commercially insured patients may pay as little as $5 copay per drug/infusion per month for up to 12 months; for additional information 844-627-3887.

Applies to:Ocrevus
Number of uses:12 times within calendar year

Patient Assistance Programs for Ocrevus

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:

  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. Medically appropriate condition/diagnosis
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.

Applicable drugs:

  • Ocrevus (ocrelizumab)

Provider: Good Days Program

Elligibility requirements:

  1. Not specified
  2. Not disclosed
  3. Not specified
  4. US residency requirements are not specified.
  5. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly.

Applicable drugs:

  • Ocrevus (ocrelizumab)

Provider: Genentech Access to Care Foundation (Ocrevus)

Elligibility requirements:

  1. Must have no prescription coverage or been denied coverage
  2. Gross annual household income at or below $100,000
  3. FDA-approved diagnosis
  4. Must be treated by US licensed healthcare provider

Applicable drugs:

  • Ocrevus (ocrelizumab)
Hide